Consensus on the treatment of vitiligo – Brazilian Society of Dermatology()()

BACKGROUND: Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease, which manifests through hypochromic or achromic macules, with loss in quality of life. The prevalence of vitiligo in Brazil was determined to be 0.54%. There is no on-label medication for its treatment. To date...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellatorre, Gerson, Antelo, Daniela Alves Pereira, Bedrikow, Roberta Buense, Cestari, Tania Ferreira, Follador, Ivonise, Ramos, Daniel Gontijo, Silva de Castro, Caio Cesar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2020
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772607/
https://www.ncbi.nlm.nih.gov/pubmed/33153826
http://dx.doi.org/10.1016/j.abd.2020.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772607/
https://www.ncbi.nlm.nih.gov/pubmed/33153826
http://dx.doi.org/10.1016/j.abd.2020.05.007

Ejemplares similares